Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03143621 · ClinicalTrials.gov registry record · NA
The Effect of Coffee After Resection of Small Bowel
A NA study, sponsored by Mount Carmel Health System.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT03143621: Completed NA study, sponsored by Mount Carmel Health System.
NCT03143621 is a NA study that has completed, run by Mount Carmel Health System. The registered enrollment target is 79 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03143621, a NA study, has completed, sponsored by Mount Carmel Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
Post-operative ileus ("post-op ileus") is a condition which can occur after surgery. This means that the bowels stop working correctly and food and liquids will not pass through in the normal manner. Post-op ileus can be uncomfortable and require a longer hospital stay until the bowels begin to function correctly again. Currently there are no effective methods for preventing post-op ileus. Some studies suggest there is a benefit from drinking coffee following colon or gynecological cancer surgeries with very little risk. However, the effects of coffee following small bowel surgery have not been studied. This randomized, controlled trial will compare the outcomes of patients who receive coffee during their hospital stay after small bowel surgery to similar patients who receive warm water. About 60 patients will be in each group. The main outcomes are time until the nasogastric tube is removed and length of hospital stay.
Primary Outcome
Time at placement to Time at removal through study completion
Interventions
- OTHER Water
- DIETARY_SUPPLEMENT Coffee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
What the finished NCT03143621 record still lists
NCT03143621 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Water is the first listed.
NCT03143621 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03143621 about?
NCT03143621 is a clinical study titled "The Effect of Coffee After Resection of Small Bowel". Post-operative ileus ("post-op ileus") is a condition which can occur after surgery. This means that the bowels stop working correctly and food and liquids will not pass through in the normal manner. Post-op ileus can be uncomfortable and require a longer hospital stay until the bowels begin to func...
What is the current status of trial NCT03143621?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2017-11-15. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT03143621?
The interventions under investigation include: Water (OTHER), Coffee (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03143621?
This trial is sponsored by Mount Carmel Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03143621's enrollment target sits among peer trials
79 1060th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI